GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells

• p38/ERK functions through a docking motif in GATA-2 to phosphorylate GATA-2 in AML cells
• p38/ERK mechanism increases GATA-2 activity at select target genes in AML cells
• GATA-2-regulated chemokine/cytokine circuit controls Kasumi-1 cell proliferation
• GATA-2-chemokine/cytokine circuit predicts poor prognosis of an AML subtype

SummaryThe master regulatory transcription factor GATA-2 triggers hematopoietic stem and progenitor cell generation. GATA2 haploinsufficiency is implicated in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), and GATA2 overexpression portends a poor prognosis for AML. However, the constituents of the GATA-2-dependent genetic network mediating pathogenesis are unknown. We described a p38-dependent mechanism that phosphorylates GATA-2 and increases GATA-2 target gene activation. We demonstrate that this mechanism establishes a growth-promoting chemokine/cytokine circuit in AML cells. p38/ERK-dependent GATA-2 phosphorylation facilitated positive autoregulation of GATA2 transcription and expression of target genes, including IL1B and CXCL2. IL-1β and CXCL2 enhanced GATA-2 phosphorylation, which increased GATA-2-mediated transcriptional activation. p38/ERK-GATA-2 stimulated AML cell proliferation via CXCL2 induction. As GATA2 mRNA correlated with IL1B and CXCL2 mRNAs in AML-M5 and high expression of these genes predicted poor prognosis of cytogenetically normal AML, we propose that the circuit is functionally important in specific AML contexts.

Graphical AbstractFigure optionsDownload as PowerPoint slide